Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
Yi‐Chen Chen(National Cheng Kung University), Qunxing Li(Guangdong Province Stomatological Hospital), Jun Cui(Xinjiang Medical University), Bin Cheng(Columbia University Irving Medical Center), Xiangqi Liu(Hebei University of Economics and Business), Lieping Chen(Yale Cancer Center), Xinye Li(Guangdong Province Stomatological Hospital), Juan Xia(University of Electronic Science and Technology of China), Jingjing Song(Qingdao University), Liqun Luo(Sun Yat-sen University), Song Guo Zheng(Songjiang District Central Hospital), Juan Fang(Guangdong Province Stomatological Hospital), Tao Liu(Jinhua University of Vocational Technology), Jun Wang(NYU Langone Health), Da Ma(Sun Yat-sen University), Shuqiong Wen(Guangdong Province Stomatological Hospital), Gucheng Zeng(Sun Yat-sen University), Dikan Wang(Guangdong Province Stomatological Hospital)
Cited by 51
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753